Tag: Cancer: Lung
Osimertinib Bests Platinum-Pemetrexed in T790M+ NSCLC
Significantly longer duration of progression-free survival with osimertinib vs platinum-pemetrexed
Intermittent Hypoxia Promotes Lung Tumor Cell Aggressiveness
IH-induced exosomes from mice significantly promote TC1 malignant properties
Updated Index Predicts Survival in NSCLC With Brain Metastases
Significant prognostic factors include four factors from earlier index, plus EGFR and ALK alterations
Pembrolizumab Ups Survival in NSCLC With PD-L1 Expression
Findings in patients with advanced NSCLC with PD-L1 expression on at least 50 percent of tumor cells
Changes in Depression Symptoms Tied to Mortality in Lung Cancer
Increased risk with new-onset depression, persistent depression, but not depression symptom remission
Lung Cancer Decision Aids Are Helpful for Patients
Patient understanding of lung cancer screening increased after participation in focus groups
ASTRO: SBRT Ups Survival in Older Early-Stage NSCLC Patients
Findings suggest SBRT should be standard for patients treated with radiation for stage I NSCLC
Similar NSCLC Survival for Surgical, Endosonographic Staging
Five-year survival not significantly different after mediastinoscopy or endosonographic staging
Whole Brain Radiotherapy Offers Little Benefit in Brain Mets
Randomized trial shows limited clinical benefit for patients with NSCLC and brain metastases
Targeted Therapies Beneficial in KRAS-Mutated NSCLC
Improved progression-free survival for patients treated with therapy not containing erlotinib
